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Abstract
Measurements of single-cell methylation are revolutionizing our understanding of epigenetic
control of gene expression, yet the intrinsic data sparsity limits the scope for quantitative anal-
ysis of such data. Here, we introduce Melissa (MEthyLation Inference for Single cell Analysis),
a Bayesian hierarchical method to cluster cells based on local methylation patterns, discovering
patterns of epigenetic variability between cells. The clustering also acts as an effective regular-
ization for data imputation on unassayed CpG sites, enabling transfer of information between
individual cells. We show both on simulated and real data sets that Melissa provides accurate
and biologically meaningful clusterings, and state-of-the-art imputation performance.
1 Background
DNA methylation is probably the best studied epigenomic mark, due to its well established heri-
tability and widespread association with diseases and a broad range of biological processes, including
X-chromosome inactivation, cell differentiation and cancer progression (Baylin and Jones, 2011; Bird,
2002; Jones, 2012). Yet its role in gene regulation, and the molecular mechanisms underpinning its
association with diseases, are still imperfectly understood.
Bisulfite treatment of DNA followed by sequencing (BS-seq) has provided a powerful tool for
measuring the methylation level of cytosines on a genome-wide scale with single nucleotide resolu-
tion (Krueger et al., 2012). BS-seq protocols have been vastly improved over the last decade, with
BS-seq rapidly becoming a widespread tool in biomedical investigation. Nevertheless, until very re-
cently BS-seq could only be used to measure methylation in bulk populations of cells (Shapiro et al.,
2013), preventing effective investigations of the role of DNA methylation in shaping transcriptional
variability and early development (Kelsey et al., 2017; Schwartzman and Tanay, 2015).
This shortcoming has been addressed within the last five years through the development of
protocols to measure DNA methylation at single-cell resolution using either scBS-seq (Smallwood
et al., 2014) or scRRBS (Guo et al., 2013) making it possible to uncover the heterogeneity and
dynamics of DNA methylation (Farlik et al., 2015). Even more recently, methods have been de-
veloped that can sequence both the methylome and the transcriptome or other features in parallel,
potentially enabling a quantification of the role of DNA methylation in explaining transcriptional
heterogeneity (Angermueller et al., 2016; Clark et al., 2018; Hou et al., 2016). However, due to the
small amounts of genomic DNA per cell, these protocols usually result in very sparse genome-wide
CpG coverage (i.e. for most CpGs we have missing values), ranging from 5% in high throughput
studies (Luo et al., 2017; Mulqueen et al., 2018) to 20% in low throughput ones (Angermueller et al.,
2016; Smallwood et al., 2014). The sparsity of the data represents a major hurdle to effectively use
single-cell methylation assays to inform our understanding of epigenetic control of transcriptomic
variability, or to distinguish individual cells based on their epigenomic state.
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In this paper, we address these problems by using a two-pronged strategy. First, we note that
several recent studies have highlighted the importance of local methylation profiles, as opposed
to individual CpG methylation, in determining the epigenetic state of a region (Kapourani and
Sanguinetti, 2016; Mayo et al., 2015; Vanderkraats et al., 2013). This implies that local spatial
correlations may be effectively leveraged to ameliorate the issue of data sparsity. Secondly, single-cell
BS-seq protocols, as all single-cell high-throughput protocols, simultaneously assay a large number
of cells, ranging from several tens (Smallwood et al., 2014) to a few thousands in the most recent
studies (Luo et al., 2017). Such abundance of data could be exploited to our advantage to transfer
information across similar cells.
We implement both of these strategies within Melissa (MEthyLation Inference for Single cell
Analysis), a Bayesian hierarchical model that jointly learns the methylation profiles of genomic
regions of interest and clusters cells based on their genome-wide methylation patterns. In this way,
Melissa can effectively use both the information of neighbouring CpGs and of other cells with similar
methylation patterns in order to predict CpG methylation states. As an additional benefit, Melissa
also provides a Bayesian clustering approach capable of identifying subsets of cells based solely on
epigenetic state, to our knowledge the first clustering method tailored specifically to this rapidly
expanding technology. We benchmark Melissa on both simulated and real single-cell BS-seq data,
demonstrating that Melissa provides both state of the art imputation performance, and accurate
clustering of cells. Furthermore, thanks to a fast variational Bayes estimation strategy, Melissa has
good scalability and can provide an effective modelling tool for the increasingly large single-cell
methylation studies which will become prevalent in coming years.
2 Results and discussion
Melissa addresses the data sparsity issue by leveraging local correlations between neighbouring CpGs
and similarity between individual cells (see Fig. 1). The starting point is the definition of a set of
genomic regions (e.g. genes or enhancers) over which the model will be applied. Within each
region, Melissa postulates a latent profile of methylation, a function mapping each CpG within the
region to a number in [0, 1] which defines the probability of that CpG being methylated. To ensure
spatial smoothness of the profile, Melissa uses a generalised linear model (GLM) of basis function
regression along the lines of Kapourani and Sanguinetti (2016) (with modified likelihood to account
for single cell data). Local correlations are however often insufficient for regions with extremely
sparse coverage, and these are quite common in scBS-seq data. Therefore, we share information
across different cells by coupling the local GLM regressions through a shared prior distribution. In
order to respect the (generally unknown) population structure that may be present within the cells
assayed, we choose a (finite) Dirichlet mixture model prior.
The output of Melissa is therefore twofold: at each genomic region in each cell, we get a predicted
profile of methylation, which can be used to impute missing data (i.e. unassayed CpGs). For each
cell, we also get a discrete cluster membership probability, providing a methylome-based clustering
of cells. This twofold output of Melissa reflects its methodological foundations as a hybrid between
a global unsupervised model (Bayesian clustering of methylomes) and a local supervised learning
model (GLM regression for every region). In this sense, Melissa is closer to a mixture of experts
model (Bishop, 2006, Chapter 14, Section 5) than a standard mixture model.
2.1 Benchmarking Melissa on simulated data
We benchmark the ability of our model to cluster and impute CpG methylation states at the
single cell level both on simulated and mouse embryonic stem cell (ESC) data sets. To assess
test prediction performance we consider different metrics, including F-measure, the area under the
receiver operating characteristic curve (AUC) and precision recall curves (Powers, 2011). We explore
the performance of a number of methods as we vary three possible experimental parameters: the
number of cells assayed, the cluster dissimilarity (how different the methylomes of cells in different
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Figure 1: Melissa model overview. Melissa combines a likelihood computed from single cell methylation
profiles fitted to each genomic region using a supervised regression approach (bottom left) and an unsupervised
Bayesian clustering prior (top left). The posterior distribution provides a methylome-based clustering (top
right) and imputation (bottom right) of single cells.
clusters are expected to be), and the CpG coverage (defined as the fraction of CpG sites covered by
at least one read, averaged over all cells).
To benchmark the performance of Melissa in predicting CpG methylation states, we compare
it against six different imputation strategies. As a baseline approach, we compute the average
methylation rate separately for each cell and region (Rate), that is, the average is taken over all CpG
sites forming a genomic region. We also use the BPRMeth model (Kapourani and Sanguinetti, 2016,
2018), where we account for the binary nature of the observations, which we train independently
across cells and regions (BPRMeth). Note that BPRMeth shares information across CpG sites inside
each genomic region, however, it does not transfer information across cells. To share information
across cells, but not across neighbouring CpGs inside the region, we constrain Melissa to infer
constant functions, i.e. learn average methylation rate (Melissa rate). We also use a Gaussian
mixture model (GMM ) that takes as input average M-values (Du et al., 2010) instead of average
methylation rates across the region (see “Methods” section); to avoid possible problems due to
high-dimensionality, the GMM method was also tested on reduced-dimensionality data, where the
first ten principal components were retained. Additionally, as a fully independent baseline, we use
a Random Forest classifier trained on individual cells and regions, where the input features are the
observed CpG locations, and the response variable is the CpG methylation state: methylated or
unmethylated (RF). This is essentially the method of Zhang et al. (2015), however, without using
additional annotation data or DNA sequence patterns. We delay comparisons with the deep learning
method DeepCpG (Angermueller et al., 2017) to the next section, as DeepCpG is not applicable in
the settings of this simulation (see later Section 2.2 and 2.4).
In order to generate realistic simulated single-cell DNA methylation data, we extracted methyla-
tion profiles from real (bulk) BS-seq data using the BPRMeth package (Kapourani and Sanguinetti,
2018), and then generated binary methylation levels at a random subset of CpGs to simulate the
low coverage of scBS-seq. In total we simulated N = 200 cells from K = 4 sub-populations, where
each cell consisted of M = 100 genomic regions. Additionally, to account for different levels of simi-
larity between cell sub-populations, we simulated 11 different datasets by varying the proportion of
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Figure 2: Melissa robustly imputes CpG methylation states. (a) Imputation performance in terms of AUC
as we vary the proportion of covered CpGs used for training. Higher values correspond to better imputation
performance. For each CpG coverage setting a total of 10 random splits of the data to training and test sets
was performed. Each coloured circle corresponds to a different simulation. The plot shows also the LOESS
curve for each method as we increase CpG coverage. The methods considered were: Melissa which shares
information across cells and neighbouring CpGs, the BPRMeth model that only shares information across
neighbouring CpGs, and a Random Forest classifier (RF ) which predicts CpG methylation states using as
input the observed CpG locations. Additionally, we considered three baseline models: Melissa Rate that
transfers information across cells but not across neighbouring CpGs using mean methylation levels across the
genomic region, a Gaussian mixture model (GMM ) that takes as input average M-values across the region,
and finally the Rate method where we compute a mean methylation rate separately for each cell and genomic
region. (b) Imputation performance measured by AUC for varying number of cells assayed. In (a) N = 200
cells were simulated and cluster dissimilarity was set to 0.5, and in (b) CpG coverage was set to 0.4 and
cluster dissimilarity to 0.5.
similar genomic regions between clusters. Finally, to assess the performance of Melissa as a function
of assayed single cells we simulated 10 different datasets by varying N , the total number of single
cells (see “Methods” section).
Applying the competing methods to synthetic data we observe that Melissa yields a substantial
improvement in prediction accuracy compared to all other models (Fig. 2, Additional file 1: Fig.
S1 and S2). Notably, Melissa is robust across different settings of the data, such as CpG coverage
proportion (Fig. 2a) or the total number of cells assayed in each experiment (Fig. 2b). Due to its
ability to transfer information across cells and neighbouring CpGs, our model robustly maintains
its prediction accuracy at a very sparse coverage level of 10% or even when assaying around 25
single cells. The BPRMeth and RF models perform poorly at low CpG coverage settings, becoming
comparable to Melissa when using the majority of the CpGs for training set. Importantly, Melissa
still performs better at 90% CpG coverage, demonstrating that the clustering acts as an effective
regularisation for imputing unassayed CpG sites. As expected, Melissa Rate and GMM have very
similar performance (due to the very similar model structure); for both methods, performance is
significantly weaker than Melissa across the full range of simulation settings, since they are not
expressive enough to capture spatial correlations between CpGs. Using GMM on reduced dimen-
sionality data did not lead to an improvement in performance, either for imputation or clustering
(data not shown). Finally, the naive Rate method has the worst imputation performance of all meth-
ods, by a considerable margin. The imputation performance of all methods is relatively insensitive
to the degree of cluster dissimilarity (Additional file 1: Fig. S2).
Next we consider the clustering performance of Melissa. Since most of the rival methods do not
have a notion of clustering, we compare Melissa to clustering using methylation rates for binary
data (Melissa Rate) or Gaussian data (GMM ) using M-values (Du et al., 2010). As a performance
metric, we use the Adjusted Rand Index (ARI) (Hubert and Arabie, 1985) between the true cluster
assignment and the predicted cluster membership returned from the model. Fig. 3a shows ARI
values comparing the three models for varying CpG coverage (with cluster dissimilarity level at
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Figure 3: Melissa efficiently and accurately clusters cell sub-populations. (a) Clustering performance mea-
sured by ARI as we vary CpG coverage. Higher values correspond to better agreement between predicted and
true cluster assignments. For each CpG coverage setting a total of 10 random splits of the data to training and
test sets was performed. Each coloured circle corresponds to a different simulation. The plot shows also the
LOESS curve for each method as we increase CpG coverage. (b) Clustering performance (ARI) for varying
proportions of similar genomic regions between clusters. (c) Clustering performance (ARI) as we vary the
total number of cells assayed. (d) Predicted number of clusters using two different prior settings: a broad and
a strict prior as we vary cluster dissimilarity. Initial number of clusters was set to K = 10. Melissa identifies
the correct number of clusters in most parameter settings (K = 4); notably when there is no dissimilarity
across clusters (i.e. we have one global cell sub-population), Melissa prunes away all components and keeps
only one cluster (K = 1).
0.5 and N = 200 cells). Melissa performs perfectly in all settings, demonstrating its power and
sensitivity in identifying robustly the cell sub-population structure. When varying the level of
cluster dissimilarity (see Fig. 3b), the model is still able to retain its high clustering performance.
As expected, for settings with low variability between clusters (i.e. cell sub-populations are difficult
to distinguish), the performance drops; however, Melissa is consistently superior to the Melissa Rate
and GMM models, and rapidly reaches near-perfect clustering accuracy. Similarly, when varying
the total number of cells assayed in each experiment (see Fig. 3c), Melissa retains its almost perfect
clustering performance and is still consistently superior than the competing models.
Subsequently, we test Melissa’s ability to perform model selection, that is to identify the appro-
priate number of cell sub-populations. To do so, we run the model on simulated data, setting the
initial number of clusters to K = 10 and letting the variational optimisation prune away inactive
clusters (Corduneanu and Bishop, 2001). We used both broad (red line) and shrinkage (blue line)
priors. Fig. 3d shows that the variational optimisation automatically recovered the correct number
of mixture components for almost all parameter settings. As expected, in settings with high between
cluster similarity, the model with shrinkage prior returned fewer clusters, since the data complexity
term in Eq. (9) (see “Methods” section) was penalizing more the variational approximation com-
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pared to the gain in likelihood from explaining the data. Finally, we assess the scalability of Melissa
with respect to the number of single cells. Additional file 1: Fig. S3 compares the variational Bayes
(red line) with the Gibbs sampling (blue line) algorithm; which demonstrates the good scalability of
variational inference where we can analyse thousands of single cells in acceptable running times. The
maximum number of iterations for the variational Bayes algorithm was set to 400 and the Gibbs
algorithm was run for 3000 iterations. Both algorithms are implemented in the R programming
language and were run on a machine utilising at most 16 CPU cores.
2.2 Benchmarking Melissa on subsampled bulk ENCODE data
The results in Section 2.1 convincingly showed a substantial advantage of Melissa over competing
methods both in terms of imputation performance and in terms of clustering. However, condi-
tioned on some seed profiles learnt from bulk data, the simulation was conducted on data which
was directly sampled from the generative Melissa model (with some additional noise), which could
conceivably introduce an unfair bias in the comparison. Additionally, since data were simulated as
separate regions, comparison with the deep learning method DeepCpG (Angermueller et al., 2017)
was not possible, since DeepCpG requires the information of a large number of neighbouring CpGs
to predict the methylation state of each target CpG site. To faithfully simulate scBS-seq data we
generated two additional synthetic datasets by directly subsampling bulk ENCODE reduced repre-
sentation bisulfite sequencing (RRBS) and whole genome bisulfite sequencing (WGBS) experiments
(see “Methods” section). For the bulk RRBS data, we randomly subsampled 10% of the mapped
reads and generated 40 pseudo-single cells from the GM12878 and H1-hESC cell lines. Due to the
higher sequencing depth of bulk WGBS experiments, only 0.5% of the mapped reads were subsam-
pled to generate pseudo-single cell methylomes. Subsequently, reads falling in the same genomic site
were binarised to obtain a digital output of methylation. Finally, the two cell lines were combined
in a single dataset of 80 pseudo-single cells prior to running Melissa. This procedure produces data
with a more similar structure to real scBS-seq data, since the uneven read coverage better captures
the structure of missing data observed in single cell epigenomic experiments.
Table 1 shows the results for the two studies when imputing CpGs falling in genomic regions of
±2.5 kb around transcription start sites (TSS) for different levels of CpG coverage. Consistently
with the simulation study in Section 2.1, Melissa performs significantly better (on scRRBS synethtic
data) or comparable (on scWGBS synthetic data) to competitors at imputation tasks. As reported
in Angermueller et al. (2017), DeepCpG performs very strongly with comparable accuracy to Melissa
across all CpG coverage settings (notice that training of DeepCpG is however slightly different, see
“Methods” section). The systematically lower performance of DeepCpG on the scRRBS dataset
is to be expected as DeepCpG relies on information from neighbouring CpGs over a large region,
Pseudo scRRBS Pseudo scWGBS
Model AUC 20% cov AUC 50% cov AUC 20% cov AUC 50% cov
Melissa 0.96 (7.3× 10−4) 0.96 (6.8× 10−4) 0.96 (6.3× 10−4) 0.96 (6.6× 10−4)
DeepCpG 0.94 (1.5× 10−3) 0.94 (1.5× 10−3) 0.96 (1.4× 10−3) 0.96 (1.4× 10−3)
BPRMeth 0.88 (2.2× 10−3) 0.91 (2.5× 10−3) 0.90 (1.9× 10−3) 0.92 (1.5× 10−3)
RF 0.79 (3.2× 10−3) 0.87 (2.0× 10−3) 0.83 (2.2× 10−3) 0.89 (2.1× 10−3)
Melissa rate 0.88 (1.8× 10−3) 0.88 (1.3× 10−3) 0.70 (2.2× 10−3) 0.71 (2.5× 10−3)
Rate 0.82 (2.6× 10−3) 0.84 (2.5× 10−3) 0.76 (4.2× 10−3) 0.77 (3.0× 10−3)
Table 1: Melissa robustly imputes CpG methylation states on subsampled ENCODE scRRBS and scWGBS
synthetic data. Imputation performance in terms of AUC as we vary the proportion of covered CpGs used
for training. Higher values correspond to better imputation performance. For each CpG coverage setting a
total of 10 random splits of the data to training and test sets was performed; shown are the mean AUC value
together with two standard deviations of the estimate in parenthesis. Note that DeepCpG was trained once
on two chromosomes, hence, the values do not change as we vary the CpG coverage.
6
and might therefore be at disadvantage for data generated using this technology. The results are
consistent across all different metrics considered in this paper and when increasing the window size
to ±5 kb around TSS (see Additional file 1: Fig. S4 - S9). Finally, Melissa could easily separate
both cell sub-populations for all settings considered in this study.
2.3 Melissa accurately predicts methylation states on real data
To assess Melissa’s performance on real scBS-seq data we considered two mouse ESC data sets from
Angermueller et al. (2016) and Smallwood et al. (2014). The mouse ESCs were cultured either in 2i
medium (2i ESCs) or serum conditions (serum ESCs), hence we expect methylation heterogeneity
between cell sub-populations. In addition, in serum ESCs there is evidence of additional CpG
methylation heterogeneity (Ficz et al., 2013), making these data suitable for the model selection
task to infer cell sub-population structure. The analysis on both data sets was performed on six
different genomic contexts: protein coding promoters with varying genomic windows: ±1.5 kb, ±2.5
kb and ±5 kb around TSS, active enhancers, super enhancers and Nanog regulatory regions (see
“Methods” section for details on data preprocessing). It should be noted that DeepCpG is designed
to predict individual missing CpGs, rather than missing regions, and requires always information
about neighbouring CpGs. This means that, during prediction, DeepCpG always has access to
more data than competing methods, potentially providing it with an unfair advantage; to partly
address this problem, we also present results when DeepCpG had access to subsampled data (labelled
DeepCpG Sub in our figures). In general, DeepCpG should be thought as complementary to Melissa,
and comparisons should be evaluated cautiously (see below Section 2.4).
We first applied Melissa on the Angermueller et al. (2016) data set which consists of 75 single cells
(14 2i ESCs and 61 serum ESCs). Fig. 4a shows a direct comparison of the imputation performance
of all the methods across a variety of genomic contexts. Melissa is better or comparable to rival
methods in terms of AUC (see Fig. 4a), and substantially more accurate in terms of F-measure
(Additional file 1: Fig. S10), demonstrating its ability to capture local CpG methylation patterns.
DeepCpG also performs strongly on most genomic regions, indicating that a flexible deep learning
method is effective in capturing patterns of methylation. Similar results were obtained by considering
different metrics (Additional file 1: Fig. S10 - S12). Boxplots show performance distributions across
10 independent training / test splits of the data, except for DeepCpG, where the high computational
costs prevented such investigation. Interestingly, methods based on methylation rates performed
poorly at promoters, underlining the importance of methylation profiles in distinguishing epigenetic
state near transcription start sites and identifying meaningful cell sub-populations. For all models,
the imputation performance (in terms of AUC) at active enhancers was lower, indicating high
methylation variability across cells and neighbouring CpG sites as shown in Smallwood et al. (2014).
In terms of clustering performance, Melissa confirms that the data supports the existence of a
sub-population of serum cells as suggested in Ficz et al. (2013), by returning three clusters in almost
all contexts. Further insights on the biological significance of the clusters obtained can be gleaned by
inspecting the inferred methylation profiles at relevant regions. Fig. 4b shows posterior methylation
profiles for three developmental genes for each cell sub-population (Additional file 1: Fig. S13 shows
additional methylation profiles of developmental genes). Each colour corresponds to a different cell
sub-population, with orange profiles corresponding to 2i ESCs which are globally hypo-methylated.
The green and purple profiles correspond to serum cells, which, as expected, present an increased
level of methylation overall. However, Melissa identifies a clear sub-population structure within
these serum cells: the purple cluster clearly represents a sub-population of cells which has only
incompletely transitioned towards the final differentiated state (high global methylation punctuated
by hypo-methylated CpG islands). Interestingly, 2i cells can be easily separated from serum cells
based on methylation rate alone, due to the global hypo-methylation of 2i cells, however the sub-
population structure within serum cells appears to be determined by changes in profiles.
As a second real data set, we analysed the smaller Smallwood et al. (2014) data set which
consists of only 32 cells (12 2i ESCs and 20 serum ESCs). The imputation performance in terms of
AUC across genomic contexts is shown in Fig. 5. Melissa retains its high prediction accuracy and is
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Figure 4: Imputation performance and clustering of mouse ESCs (Angermueller et al., 2016) based on genome
wide methylation profiles. (a) Prediction performance on test set for imputing CpG methylation states in
terms of AUC. Higher values correspond to better imputation performance. Each coloured boxplot indicates
the performance using 10 random splits of the data in training and test sets; due to high computational costs,
DeepCpG was trained only once and the boxplots denote the variability across ten random subsamplings of
the test set. (b) Example promoter regions with the predicted methylation profiles for three developmental
genes: Myc, Esrrb and Nog. Each coloured profile corresponds to the average methylation pattern of the cells
assigned to each sub-population, in our case Melissa identified K = 3 clusters.
comparable with DeepCpG across most contexts (see Additional file 1: Fig. S14 - S16 for performance
on different metrics), even though the full DeepCpG model has slightly better performance on this
data set. This suggests that the small number of cells in this data set did not allow an effective
sharing of information. In terms of clustering performance, Melissa identifies three clusters in the
vast majority of settings, once again underlying the emergence of epigenomically distinct populations
within serum cells (see Additional file 1: Fig. S17 and S18 for example methylation profiles across
genomic contexts).
2.4 A note on the comparison with DeepCpG
Melissa and DeepCpG models reported substantially better imputation performance compared to
the rival methods and show comparable performance when analysed on real datasets, demonstrating
their flexibility in capturing complex patterns of methylation. However, the two methods have
significantly different computational performances. In our experiments, Melissa’s runtime was less
than six hours for all genomic contexts running on a small server machine utilising at most ten
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Figure 5: Imputation performance of mouse ESCs (Smallwood et al., 2014) based on genome wide methyla-
tion profiles. Shown is the prediction performance, in terms of AUC, for imputing CpG methylation states.
Each coloured boxplot indicates the performance using 10 random splits of the data in training and test sets;
due to high computational costs, DeepCpG was trained only once and the boxplots denote the variability
across ten random subsamplings of the test set.
CPU cores (see Additional file 1: Table S1 and S2). By contrast, DeepCpG required around three
to four days to analyse each dataset on a GPU cluster equipped with high end NVIDIA Tesla
K40ms GPUs, and had very high memory requirements. These computational overheads effectively
make DeepCpG out of reach for smaller research groups. On the other hand, Melissa operates on
a set of genomic contexts of interest (e.g. promoters), while DeepCpG is designed for genome-wide
imputation; computational performance of both methods will therefore depend on specific choices,
such as the size/ number of the regions of interest for Melissa, or the number of training chromosomes
for DeepCpG.
In addition to the differences in scope between the two methods, one should also be cautious
when directly comparing prediction performances due to the different design of the DeepCpG model.
DeepCpG is trained on a specific set of chromosomes and considers each CpG site independently;
hence it does not have a notion of genomic region to be trained on, and will in any case utilize
information from neighbouring CpGs within or outside the region, information that Melissa and the
rival methods do not have access to.
3 Conclusions
Single cell DNA methylation measurements are rapidly becoming a major tool to understand epi-
genetic gene regulation in individual cells. Newer platforms are rapidly expanding the scope of the
technology in terms of assaying large numbers of cells (Luo et al., 2017), however all technologies
are plagued by intrinsically low coverage in terms of numbers of CpGs assayed.
In this paper, we have proposed Melissa as a way of addressing the low coverage issue by sharing
information between CpGs with a local smoothing and between cells with a Bayesian clustering
prior. On both synthetic and real data, Melissa achieved state of the art imputation performance
over a panel of competing methods, including DeepCpG (Angermueller et al., 2017) and random
forests. While achieving comparable or superior performance to black-box methods, such as neural
networks and random forests, Melissa is more transparent and needs minimal tuning: all the results
shown, on both synthetic and real data, were obtained with the same settings of the algorithm. Ad-
ditionally, as all Bayesian methods, Melissa outputs are probability distributions that fully quantify
the uncertainty on the model’s prediction, and which are more easily usable for further experimen-
tal design compared to the point-estimates provided by black-box approaches. Melissa does not
require additional annotation data as in Zhang et al. (2015) or Ernst and Kellis (2015), and does
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not exploit sequence information like DeepCpG, but an extension leveraging side data would be
easily accomplished within the Bayesian framework and would represent an interesting extension
for future research. By using a Bayesian clustering prior, Melissa has the added benefit of simulta-
neously uncovering the population structure within the assay, as we demonstrated in the real data
examples; Melissa can therefore be a useful tool in uncovering epigenetic diversity among cells.
In addition, in this work Melissa was applied on pre-defined genomic regions of interest, such as
promoters and enhancers, however, one could easily perform genome-wide imputation and clustering
of single cell methylomes by using a sliding (non-overlapping) window approach. While this paper
was under review, we became aware of a new preprint describing Epiclomal (de Souza et al., 2018), a
method to perform clustering of single cell DNA methylomes using a Bayesian probabilistic model.
Epiclomal shares a similar hierarchical structure to Melissa, and also models bisulfite conversion
error; however, Epiclomal does not model the spatial variability of neighbouring CpGs, and therefore
cannot perform imputation as Melissa does.
While Melissa accounts for heterogeneity in the cell population structure, it does not allow for
heterogeneity at the single gene level: each cluster has a single methylation profile within each
region, and all variability at the single locus level is attributed to noise. This rigidity limits the
usefulness of Melissa as a tool to investigate intrinsic stochasticity in methylation at the single locus
level. Relaxing the modelling assumptions to accommodate methylation variability in Melissa is an
interesting topic for future research. Another area where Melissa could be fruitfully applied is the
integrative study of multiple high-throughput features in single cells. Kapourani and Sanguinetti
(2016) showed that features extracted from methylation profiles could be effectively used to predict
gene expression in bulk experiments. With the advent of novel technologies measuring gene expres-
sion and multiple epigenomic features in individual cells (Clark et al., 2018), interpretable Bayesian
models like Melissa are likely to play an important role in furthering our understanding of epigenetic
control of gene expression in single cells.
4 Methods
4.1 Melissa model
In order to provide spatial smoothing of the methylation profiles at specific regions, we adapt a
generalised linear model of basis function regression proposed recently in Kapourani and Sanguinetti
(2016) and further extended and implemented in the BPRMeth Bioconductor package in (Kapourani
and Sanguinetti, 2018). The basic idea of BPRMeth is as follows: the methylation profile associated
with a genomic region m is defined as a (latent) function f : m → (0, 1) which takes as input the
genomic coordinate along the region and returns the propensity for that locus to be methylated.
For single-cell methylation data, methylation of individual CpG sites can be naturally modelled
using a Bernoulli observation model, since for the majority of covered sites we have binary CpG
methylation states (see Additional file 1: Fig. S13). More specifically, for a specific region m, we
model the observed methylation of CpG site i as
ymi ∼ Bern(ρmi), (1)
where the unknown “true” methylation level ρmi has as covariates the CpG locations xmi. Then,
we define the BPRMeth model as
ηmi = w
>
mh(xmi),
fm(xmi) = ρmi = g
−1(ηmi),
(2)
where wm are the regression coefficients, xmi ≡ h(xmi) are the basis function transformed CpG
locations (here we consider radial basis functions (RBFs)), and g(·) is the link function that allows
us to move from the systematic components ηmi to mean parameters ρmi. Here we consider a probit
regression model which is obtained by defining g−1(·) = Φ(·) — where Φ(·) denotes the cdf of the
standard normal distribution — ensuring that f takes values in the [0, 1] interval. Notice that both
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BPRMeth and Melissa do not explicitly model bisulfite conversion errors. Conversion errors are
estimated to be relatively rare and below 1% according to Genereux et al. (2008), and we show
in our simulation studies that Melissa is highly robust to the addition of noise mimicking possible
errors.
To account for the limited CpG coverage of scBS-seq experiments, the BPRMeth model was
recently reformulated in a Bayesian framework (Kapourani and Sanguinetti, 2018). The model was
made amenable to Bayesian estimation thanks to a data augmentation strategy originally proposed
by Albert and Chib (1993). This strategy consists of introducing an additional auxiliary latent vari-
able zi, which has a Gaussian distribution conditioned on the input w
>xi, leading to the graphical
model in Fig. 6.
yi
zi
xi w
τ
I CpGs
τ ∼ Gamma(τ |α0, β0)
w | τ ∼ N (w |0, τ−1I)
zi |w,xi ∼ N (zi |w>xi, 1)
yi | zi =
{
1 if zi > 0
0 if zi ≤ 0
Figure 6: Probabilistic graphical representation of the BPRMeth model.
The BPRMeth model is limited to sharing information across CpGs via local smoothing (which
certainly helps in dealing with data sparsity), however, in our experience the coverage in scBS-seq
data is insufficient to infer informative methylation profiles at many genomic regions. We therefore
propose Melissa to exploit the population structure of the experimental design and additionally
share and transfer information across cells.
Assume that we have N(n = 1, ..., N) cells and each cell consists of M(m = 1, ...,M) genomic
regions, for example promoters, and we are interested in both partitioning the cells in K clusters
and inferring the methylation profiles for each genomic region. To do so, we use a finite Dirichlet
mixture model (FDMM) (McLachlan and Peel, 2004), where we assume that the methylation profile
of the mth region for each cell n is drawn from a mixture distribution with K components (where
K < N). This way cells belonging to the same cluster will share the same methylation profile,
although profiles will still differ across genomic regions. Let cn be a latent variable comprising a
1-of-K binary vector with elements cnk representing the component that is responsible for cell n,
and pik be the probability that a cell belongs to cluster k, i.e. pik = p(cnk = 1). The conditional
distribution of C = {c1, . . . , cN} given pi is
p(C |pi) =
N∏
n=1
K∏
k=1
picnkk . (3)
Considering the FDMM as a generative model, the latent variables cn will generate the latent
observations Zn ∈ RM×Im , which in turn will generate the binary observations Yn ∈ {0, 1}M×Im
depending on the sign of Zn, as shown in Fig. 6. The conditional distribution of the data (Z,Y),
given the latent variables C and the component parameters W becomes
p(Y,Z |C,W,X) =
N∏
n=1
K∏
k=1
[
M∏
m=1
p(ynm | znm) p(znm |wmk,Xnm)
]cnk
, (4)
where
p(ynm | znm) = I(znm > 0)ynmI(znm ≤ 0)(1−ynm).
To complete the model we introduce priors over the parameters. We choose a Dirichlet distribution
over the mixing proportions, p(pi) = Dir(pi | δ0), where for symmetry we choose the same parameter
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δ0k for each of the mixture components. We also introduce an independent Gaussian prior over the
coefficients W, that is,
p(W | τ ) =
M∏
m=1
K∏
k=1
N (wmk |0, τ−1k I). (5)
Finally, we introduce a prior distribution for the (hyper)-parameter τ , and assume that each cluster
has its own precision parameter, p(τk) = Gamma(τk |α0, β0). Having defined our model, we can now
write the joint distribution over the observed and latent variables
p(Y,Z,C,W,pi, τ |X) =p(Y |Z) p(Z |C,W,X) p(C |pi) p(pi) p(W | τ ) p(τ ), (6)
where the factorisation corresponds to the probabilistic graphical model shown in Fig. 7.
ynmi
znmi
xnmi
cn
pi
wmk τk
I CpGs
K clusters
M regions
N cells
pi ∼ Dir(δ0)
cn |pi ∼ Discrete(pi)
τk ∼ Gamma(α0, β0)
wmk | τk ∼ N (0, τ−1k I)
znmi |wmk,xnmi ∼ N (w>mkxnmi, 1)
ynmi | znmi =
{
1 if znmi > 0
0 if znmi ≤ 0
Figure 7: Probabilistic graphical representation of the Melissa model.
Importantly, Melissa is a hybrid between a global unsupervised clustering model and a local
supervised prediction model, encoded through the GLM regression coefficients w for each genomic
region. When considering Melissa as an imputation (or predictive) model, the training data are
coming by using only a subset of CpG tuples (xnmi, ynmi) for each region. For example, from the
observed Inm CpGs in a given region, Melissa will only see Inm/2 random CpGs during training,
and the remaining CpGs will be used as a held out test set to evaluate its prediction performance.
Note that in any case, either using all CpGs or a subset during training, Melissa will additionally
perform clustering at the global level which is encoded through the latent variables cn.
Variational Inference
The posterior distribution of the latent variables given the observed data p(Z,C,W,pi, τ |Y,X)
for the Melissa model is not analytically tractable; hence, we resort to approximate techniques.
The most common method for approximate Bayesian inference is to perform Markov Chain Monte
Carlo (MCMC) (Gelfand and Smith, 1990), however, sampling methods require considerable com-
putational resources and do not scale well when performing genome-wide analysis on hundreds or
thousands of single cells. Variational methods can provide an efficient, approximate solution with
better scalability in this case (see “Results” section for a comparison between Gibbs sampling and
variational inference for this model). More specifically, we use mean-field variational inference (Blei
et al., 2017) which assumes that the approximating distribution factorises over the latent variables,
q(Z,C,W,pi, τ ) = q(Z) q(C) q(W) q(pi) q(τ ). (7)
Detailed mathematical derivations of the optimal variational factors are available in Additional file
1: Section 1. Next we iteratively update each factor q while holding the remaining factors fixed using
the coordinate ascent variational inference (CAVI) algorithm which is summarised in Algorithm 1.
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Algorithm 1 CAVI for Melissa model
1: initialize Gaussian factor λ,S; Dirichlet factor δ0; and Gamma factor α0, β0.
2: Update αk ← α0 +MD/2
3: Update βk ← β0
4: while ELBO has not converged do
5: Set γnmk = (znm −Xnmwmk) . Variational E-step
6: Update rnk ∝ 〈lnpik〉q(pik) +
∑
m
〈−12γ>nmkγnmk〉q(znm,wmk)
7: . Variational M-step
8: Update δk ← δ0k +
∑
n rnk . Dirichlet distribution parameter
9: Update βk ← β0 + 12
∑
m
〈
w>mkwmk
〉
q(wmk)
. Gamma distribution parameter
10: Update µnmi ←
∑
k rnk
〈
w>mkxnmi
〉
q(wmk)
. Mean of truncated Gaussian
11: Set 〈znmi〉q(znmi) =
{
µnmi + φ(−µnmi)/
(
1− Φ(−µnmi)
)
if ynmi = 1
µnmi − φ(−µnmi)/Φ(−µnmi) if ynmi = 0
12: Update Smk ←
(
αk
βk
I+
∑
n rnkX
>
nmXnm
)−1
. Regression coefficient covariance
13: Update λmk ← Smk
∑
n rnkX
>
nm 〈znm〉q(znm) . Regression coefficient mean
14: Update L (q(W,Z,C,pi, τ )) . Compute ELBO
15: end while
Predictive density and model selection
Given an approximate posterior distribution, we are in the position to predict the methylation level
at unobserved CpG sites. The predictive density of a new observation y∗, which is associated with
latent variables c∗, z∗ and covariates X∗, is given by
p(y∗ |X∗,Y) =
∑
c∗
∫ ∫
p(y∗, c∗, z∗,θ |X∗,Y)dθdz∗
'
K∑
k=1
δk∑
j δj
Bern
y∗∣∣∣Φ
 X∗λk√
I+ diag
(
X∗SkXT∗
)
 (8)
where we collectively denote as θ the relevant parameters being marginalised.
It has been repeatedly observed (Corduneanu and Bishop, 2001) that, when fitting variationally
a mixture model with a large number of components, the variational procedure will prune away
components with no support in the data, hence effectively determining an appropriate number of
clusters in an automatic fashion, i.e. perform model selection. We can gain some intuition as to why
this happens in the following way. We can rewrite the Kullback-Leibler (KL) divergence as
KL(q(θ) || p(θ |X)) = ln p(X)− 〈ln p(X |θ)〉q(θ) +KL(q(θ) || p(θ)) (9)
where ln p(X) can be ignored since is constant with respect to q(θ). To minimize this objective func-
tion the variational approximation will both try to increase the expected log likelihood of the data
ln p(X |θ) while minimizing its KL divergence with the prior distribution p(θ). Hence, using varia-
tional Bayes we have an automatic trade-off between fitting the data and model complexity (Bishop,
2006).
4.2 Assessing Melissa via a simulation study
To generate realistic simulated single-cell methylation data, we first used the BPRMeth pack-
age (Kapourani and Sanguinetti, 2018) to infer five prototypical methylation profiles from the
GM12878 lymphoblastoid cell line. The bulk BS-seq data for the GM12878 cell line are publicly
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available from the ENCODE project (Dunham et al., 2012). Based on these profiles we simulated
single cell methylation data (i.e. binary CpG methylation states) for M = 100 genomic regions, where
each CpG was generated by sampling from a Bernoulli distribution with probability of success given
by the latent function evaluation at the specific site. To mimic the inherent noise introduced by
bisulfite conversion error, Gaussian noise N (µ = 0, σ = 0.05) was introduced to the probability of
success prior to generating each binary CpG site. This process can be thought of as generating
methylation data for a specific single cell. Next, we generated K = 4 cell sub-populations by ran-
domly shuﬄing the genomic regions across clusters, so now each cell sub-population has its own
methylome landscape. In total we generated N = 200 cells, with the following cell sub-population
proportions: 40%, 25%, 20% and 15%. Additionally, to account for different levels of similarity be-
tween cell sub-populations, we simulated 11 different datasets by varying the proportion of similar
genomic regions between clusters. Finally, to assess the performance of Melissa for varying number
of cells assayed we simulated 10 different datasets by varying the total number of single cells N. The
scripts (written in the R programming language) for this simulation study are publicly available on
the Melissa repository.
4.3 Assessing Melissa on subsampled bulk ENCODE data
To faithfully simulate methylation data that resemble scBS-seq experiments, we generated two ad-
ditional synthetic datasets by subsampling bulk ENCODE RRBS (GEO: GSE27584) and WGBS
(GEO: GSE80911 for H1-hESC and GSE86765 for GM12878) data, each consisting of two different
cell lines, H1-hESC and GM12878. The RRBS data are enriched for genomic regions with high
CpG content (using methylation sensitive restriction enzymes such as MspI that recognises CCGG
motifs) which predominantly reside near promoter regions and CpG islands. On the other hand,
WGBS experiments in theory can assay the whole methylome landscape of the human genome,
however, they require high sequencing depth to obtain an accurate estimate of the bulk methylation
level at each CpG site. To retain the structure of missing data observed in scBS-seq experiments
(due to read length), we directly subsampled the raw FASTQ files which essentially lead to dis-
carding individual reads rather than individual CpGs. For the RRBS dataset, from each cell line
we generated 40 pseudo-single cells by randomly keeping 10% of the mapped reads from the bulk
experiment, resulting in 80 cells when combining both cell lines. For the WGBS dataset, the same
number of pseudo-single cells was generated from each cell line, with the only difference that only
0.5% of the mapped reads were retained from the bulk data due to the high sequencing depth of the
experiments. This process was performed for chromosomes 1 to 6 to alleviate the computational
burden. Subsequently, the same preprocessing steps detailed in Section 4.4 were performed, with the
only difference that for this study we considered only ±2.5 kb and ±5 kb promoter regions around
TSS. Each model, except DeepCpG, used 20%, 50% and 80% of the CpGs as training set, and the
remaining of CpGs were used as a test set to evaluate imputation performance. The DeepCpG
model used chromosomes 1 and 3 as training set, chromosome 5 as validation set and the remaining
chromosomes as test set.
4.4 scBS-seq data and preprocessing
Single cell bisulfite sequencing protocols provide us with single base-pair resolution of CpG methy-
lation states. Since we assay the DNA of a single cell, the methylation level for each CpG site
is predominantly binary, either methylated or unmethylated. However, due to each chromosome
having two copies, a small proportion of CpG sites have a non-binary nature (see Additional file
1: Fig. S19). To avoid ambiguities, hemi-methylated sites — sites with 50% methylation level —
are filtered prior to downstream analysis, and for the remaining sites binary methylation states
are obtained from the ratio of methylated read counts to total read counts, in a similar fashion
to Angermueller et al. (2016).
Two mouse embryonic stem cells (ESCs) datasets were used to validate the performance of the
Melissa model. The first dataset presented in Angermueller et al. (2016), after quality assessment,
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consisted of 75 single cells out of which 14 cells were cultured in 2i medium (2i ESCs) and the remain-
ing 61 cells were cultured in serum conditions (serum ESCs). The Bismark (Krueger and Andrews,
2011) processed data, with reads mapped to the GRCm38 mouse genome, were downloaded from
the Gene Expression Omnibus under accession GSE74535. The second dataset (Smallwood et al.,
2014) contained 32 cells out of which 12 cells were 2i ESCs and the remaining 20 cells were serum
ESCs and the Bismark processed data, with reads mapped to the GRCm38 mouse genome, are
publicly available under accession number GSE56879. For both datasets, the observed data that are
used as input to Melissa, are binary methylation states: unmethylated CpGs are encoded with zero
and methylated CpGs with one. We should note that this is the standard procedure for processing
scBS-seq data (Smallwood et al., 2014) and additional information and visualisations regarding the
quality of the scBS-seq data can be found in the original publications.
Since Melissa considers genomic regions for a specific genomic context, we use the BPRMeth
package (Kapourani and Sanguinetti, 2018) to filter CpGs that do not fall inside these regions, and
create a simple data structure where each cell is a encoded as a list, and each entry of the list —
corresponding to a specific genomic region — is a matrix with two columns: the (relative) CpG
location and the methylation state. We considered six different genomic contexts where we applied
Melissa: protein coding promoters with varying genomic windows: ±1.5 kb, ±2.5 kb and ±5 kb
around transcription start sites (TSS), active enhancers, super enhancers and Nanog regulatory
regions. Due to the sparse CpG coverage, for the three genomic contexts except promoters we
filtered loci with smaller than 1 kb annotation length and specifically for Nanog regions we took a
window of ±2.5 kb around the centre of the genomic annotation. In addition, we only considered
regions that were covered in at least 50% of the cells with a minimum coverage of 10 CpGs and had
between cell variability; the rationale being that homogeneous regions across cells do not provide
additional information for identifying cell sub-populations. The CpG coverage distribution after
the filtering process across different genomic contexts is shown in Additional file 1: Fig. S20 and
S21. The sparsity level of the two scBS-seq datasets across different genomic contexts is shown in
Additional file 1: Table S3. It should be noted, that imputation performance is evaluated only on
genomic regions that pass the filtering threshold. We run the model with K = 6 and K = 5 clusters
for the Angermueller et al. (2016) and Smallwood et al. (2014) datasets, respectively, and we use a
broad prior over the model parameters.
4.5 Performance evaluation
To assess model performance across all genomic contexts, we partition the data and use 50% of the
CpGs in each cell and region for training set and the remaining 50% as test set (except DeepCpG,
see below). The prediction performance of all competing models, except DeepCpG, was evaluated
on imputing all missing CpG states in a given region at once. For computing binary evaluation
metrics, such as F-measure, predicted probabilities above 0.5 were set to one and rounded to zero
otherwise.
F-measure The F-measure or F1-score is the harmonic mean of precision and recall:
F -measure = 2 · precision · recall
precision + recall
. (10)
Gaussian mixture model The input to the Gaussian mixture model (GMM) is the average
methylation rate across the region; since rates are between (0,1) we transform them to M-values,
which follow closer the Gaussian distribution (Du et al., 2010). The transformation from average
methylation rates to average M-values is obtained by
M -value = log2
(
rate + 0.01
1− rate + 0.01
)
. (11)
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Adjusted Rand Index The Adjusted Rand Index (ARI) is a measure of the similarity between
two data clusterings:
ARI =
∑
ij
(nij
2
)− [∑i (αi2 )∑j (βj2 )] /(n2)
1
2
[∑
i
(
αi
2
)
+
∑
j
(βj
2
)]− [∑i (αi2 )∑j (βj2 )] /(n2) . (12)
DeepCpG
The DeepCpG method takes a different imputation approach: it is trained on a specific set of
chromosomes and predicts methylation states on the remaining chromosomes where it imputes each
CpG site sequentially by using as input a set of neighbouring CpG sites. This approach makes
it difficult to equally compare with the rival methods, since for each CpG the input features to
DeepCpG are all the neighbouring sites, whereas the competing models have access to a subset of
the data and they make predictions in one pass for the whole region. Since we only had access
to CpG methylation data and to make it comparable with the considered methods, we trained the
CpG module of DeepCpG (termed DeepCpG CpG in Angermueller et al. (2017)).
For the Angermueller et al. (2016) dataset, chromosomes 3 and 17 were used as training set,
chromosomes 12 and 14 as validation set and the remaining chromosomes as test set. For the
Smallwood et al. (2014) dataset, chromosomes 3, 17 and 19 were used as training set, chromosomes
12 and 14 as validation set and the remaining chromosomes as test set. The chosen chromosomes
had at least 3 million CpGs used as training set; a sensible size for the DeepCpG model as suggested
by the authors. A neighbourhood of K = 20 CpG sites to the left and the right for each target
CpG was used as input to the model. During testing time, even if a given genomic region did
not contain at least 40 CpGs, the DeepCpG model used additional CpGs outside this window to
predict methylation states; hence using more information compared to the rival models. In total
the DeepCpG model took around four days per dataset for training and prediction on a cluster
equipped with NVIDIA Tesla K40ms GPUs.
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